Vaccine coverage, % (95% CI) | Number of individuals investigated | |
---|---|---|
Age group | ||
< 18 years | 6.5 (4.4–8.7) | 516 |
< 5 years | 5.2 (0.1–10.3) | 74 |
5–14 years | 6.4 (3.6–9.2) | 294 |
14–17 years | 7.4 (3.2–11.6) | 148 |
18–64 years | 11.1 (9.4–12.2) | 3306 |
18–29 years | 4.2 (2.7–5.7) | 723 |
30–55 years | 10.8 (9.4–12.2) | 1813 |
56–59 years | 15.1 (11.6–18.6) | 393 |
60–64 years | 24.6 (20.3–28.9) | 379 |
≥ 65 years | 58.0 (56.6–59.5) | 4433 |
65–69 years | 40.6 (38.1–43.1) | 1498 |
70–80 years | 54.1 (52.2–56.0) | 2628 |
> 80 years | 73.5 (68.6–78.4) | 307 |